Radiotherapy for pediatric brain tumors: when and how

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Neuro-oncology

Background:

• Historically, surgery was the primary treatment for pediatric central nervous system (CNS) malignancies.
• Radiotherapy integration over 75 years has transformed outcomes for many pediatric brain tumors.
• Multimodality treatments combining surgery, chemotherapy, and radiotherapy are now standard.

Purpose of the Study:

• To detail the role of radiotherapy in pediatric brain tumor treatment.
• To discuss the significant long-term central nervous system (CNS) side effects of radiotherapy in survivors.
• To summarize current research aimed at mitigating these treatment-related toxicities.

Main Methods:

• Review of historical treatment paradigms for pediatric CNS malignancies.
• Analysis of radiotherapy's evolving role as adjuvant, definitive, or prophylactic therapy.
• Examination of long-term neurotoxicity data and ongoing research initiatives.

Main Results:

• Radiotherapy has dramatically increased cure rates for previously fatal pediatric brain tumors.
• Significant long-term central nervous system (CNS) side effects are a major concern for survivors.
• Ongoing research focuses on developing strategies to reduce radiotherapy-induced toxicities.

Conclusions:

• Radiotherapy is indispensable in modern pediatric brain tumor management, offering curative potential.
• Addressing and minimizing long-term CNS side effects is critical for improving survivors' quality of life.
• Continued research into novel therapeutic approaches is essential for safer and more effective pediatric neuro-oncology care.